Efficiency of P‐glycoprotein–Mediated Exclusion of Rhodamine Dyes from Multidrug‐Resistant Cells is Determined by their Passive Transmembrane Movement Rate
Open Access
- 1 August 1997
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 248 (1) , 104-112
- https://doi.org/10.1111/j.1432-1033.1997.00104.x
Abstract
The aim of the present study was to examine the relationship between the rate of the passive transmembrane movement of multidrug resistance (MDR)‐type substrates and the ability of P‐glycoprotein to extrude them from MDR cells. For this purpose, seven rhodamine dyes were examined for their P‐glycoprotein–mediated exclusion from MDR cells, their localization in wild‐type drug‐sensitive cells, their capacity to stimulate the ATPase activity of P‐glycoprotein reconstituted in proteoliposomes, and their transmembrane movement rate in artificial liposomes. All these rhodamine dyes were accumulated in wild‐type drug‐sensitive cells and were localized mainly in the mitochondria. All the dyes tested were substrates of reconstituted P‐glycoprotein and cellular P‐glycoprotein and were excluded to a variable degree from MDR cells. The transmembrane movement rate proved the major factor determining the efficacy of the P‐glycoprotein–mediated exclusion of rhodamine dyes from MDR cells. Thus, rhodamine B, the poorest cellular P‐glycoprotein substrate, exhibited a high affinity toward reconstituted P‐glycoprotein, but was the fastest membrane‐traversing dye. In contrast, tetramethylrosamine, the best cellular MDR probe, exhibited high affinity toward reconstituted P‐glycoprotein and slow transmembrane movement rate. Therefore, an anticancer drug with a fast transmembrane movement rate is expected to over‐come the MDR phenomenon. Furthermore, the widely used MDR marker, rhodamine 123, was a poor cellular MDR substrate compared with other rhodamine dyes, especially tetramethylrosamine, which was a superior cellular MDR substrate for functional dye‐exclusion studies.Keywords
This publication has 25 references indexed in Scilit:
- The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its ModulationJournal of Biological Chemistry, 1996
- Potentiation of Anticancer-Drug Cytotoxicity by Multidrug-Resistance Chemosensitizers Involves Alterationsin Membrane Fluidity Leading to Increased Membrane PermeabilityEuropean Journal of Biochemistry, 1995
- Characterization of the ATPase Activity of Purified Chinese Hamster P-glycoproteinBiochemistry, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamicsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1990
- Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomenaBiochemistry, 1990
- Multidrug Resistance: P-glycoprotein and Its Allies--The Elusive FoesJNCI Journal of the National Cancer Institute, 1989
- The Biochemistry Of P-Glycoprotein-Mediated Multidrug ResistanceAnnual Review of Biochemistry, 1989
- Cellular and Tissue Distribution of MRK20 Murine Monoclonal Antibody‐defined 85‐kDa Protein in Adriamycin‐resistant Cancer Cell Lines*1Japanese Journal of Cancer Research, 1988
- The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984